Back to top
more

Arotech Corporation (ARTX)

(Delayed Data from NSDQ)

$2.89 USD

2.89
69,590

+0.02 (0.70%)

Updated May 3, 2019 04:00 PM ET

After-Market: $2.88 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Arotech (ARTX) Q3 Earnings Match Estimates

by Zacks Equity Research

Arotech (ARTX) delivered earnings and revenue surprises of 0.00% and -10.87%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Arotech (ARTX) Reports Next Week: What to Expect

by Zacks Equity Research

Arotech (ARTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should Value Investors Buy Arotech (ARTX) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Arotech (ARTX) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Arotech (ARTX) delivered earnings and revenue surprises of 200.00% and 7.82%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for May 17th

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

Arotech (ARTX) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

Arotech (ARTX) delivered earnings and revenue surprises of -200.00% and -13.78%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Arotech (ARTX) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Arotech (ARTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Arotech (ARTX) Catches Eye: Stock Jumps 7%

by Zacks Equity Research

Arotech (ARTX) saw a big move last session, as its shares jumped 7% on the day, amid huge volumes.

Arotech (ARTX) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Arotech (ARTX) delivered earnings and revenue surprises of 200.00% and 1.46%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Arotech (ARTX) Q3 Earnings Expected to Decline

by Zacks Equity Research

Arotech (ARTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Arotech (ARTX) Matches Q2 Earnings Estimates

by Zacks Equity Research

Arotech (ARTX) delivered earnings and revenue surprises of 0.00% and -7.90%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

    New Strong Sell Stocks for December 7th

    by Zacks Equity Research

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

      L3 Technologies Wins $49M Deal to Upgrade SATCOM Terminals

      by Zacks Equity Research

      L3 technologies' (LLL) Communications Systems segment offers airborne, space and surface data link terminals, ground stations, and transportable tactical SATCOM systems

        Should You Add L3 Technologies (LLL)) to Your Portfolio?

        by Zacks Equity Research

        L3 Technologies (LLL) follows a disciplined divestment strategy to efficiently focus on its core operations. However, it faces strong competition from peers.

          L3 Technologies Clinches Commercial Contracts Worth $115M

          by Zacks Equity Research

          Apart from exploiting its legacy defense business that includes unmanned systems equipment and secure communication systems, L3 Technologies (LLL) also holds a strong ground in the commercial aviation space.

            L3 Technologies Wins $83M Deal for TH-57's Support Service

            by Zacks Equity Research

            Going ahead, L3 Technologies (LLL) expects to gradually transform its business portfolio to focus on defense electronics, communications and ISR markets.

              FLIR Systems (FLIR) Reports In-Line Earnings in Q1, Sales Up

              by Zacks Equity Research

              FLIR Systems' (FLIR) first-quarter 2017 earnings were in line with estimates.

                L3 Technologies' Acquisitions, Solid Cash Balance Impress

                by Zacks Equity Research

                In Jan 2017, L3 Technologies (LLL) completed the buyout of Implant Sciences' explosives trace detection (ETD) assets to increase its capabilities in the global aviation security

                  Arotech (ARTX) Shares March Higher, Can It Continue?

                  by Zacks Equity Research

                  As of late, it has definitely been a great time to be an investor in Arotech Corporation (ARTX).

                    L3 Technologies Acquires ETD Assets of Implant Sciences

                    by Zacks Equity Research

                    L3 Technologies (LLL) completed the acquisition of Implant Sciences' explosives trace detection (ETD) assets.

                      FLIR Systems Unveils Thermal Camera Lineup at CES 2017

                      by Zacks Equity Research

                      FLIR Systems, Inc. (FLIR) recently unveiled a camera lineup at CES 2017, an eventful consumer electronics and technology trade show frequented by tech biggies to introduce latest offerings.

                        Arotech, Cooper Companies, UnitedHealth Group, Aetna and Humana highlighted as Zacks Bull and Bear of the Day

                        by Zacks Equity Research

                        Arotech, Cooper Companies, UnitedHealth Group, Aetna and Humana highlighted as Zacks Bull and Bear of the Day

                          Brian Bolan headshot

                          Bull of the Day: Arotech Corp (ARTX)

                          by Brian Bolan

                          This small cap is a perfect fit for investors looking for a "Trump Bump."

                            Has the Defense Industry Outlook Really Improved?

                            by Zacks Equity Research

                            Increasing threats, uncertainty and the rising need to safeguard the interest of nations and people have pushed up demand for weapons.

                              Zacks Investment Ideas feature highlights: Arotech, Braksem, BHP Billiton, Suncor Energy and Thor Industries

                              by Zacks Equity Research

                              Zacks Investment Ideas feature highlights: Arotech, Braksem, BHP Billiton, Suncor Energy and Thor Industries